Yayın:
Prognostic factors in medically inoperable early stage lung cancer patients treated with stereotactic ablative radiation therapy (SABR): Turkish Radiation Oncology Society Multicentric Study

Sadeleştirilmiş öğe sayfası
dc.contributor.authorÇağlar, Hale Başak
dc.contributor.authorBanu Atalar
dc.contributor.authorEsra Sağlam
dc.contributor.authorZüleyha Akgün
dc.contributor.authorUfuk Abacıoğlu
dc.contributor.authorA. Arifoglu
dc.contributor.authorEnis Özyar
dc.contributor.authorGökhan Yaprak
dc.contributor.authorNaciye Isık
dc.contributor.authorYıldız Güney
dc.contributor.authorHale Başak Çağlar
dc.contributor.authorŞule Karaman
dc.contributor.authorŞefik İğdem
dc.contributor.authorUğur Selek
dc.contributor.authorTanju Berber
dc.contributor.authorFazilet Öner Dinçbaş
dc.contributor.authorMeriç Şengöz
dc.contributor.authorSerap Yücel
dc.contributor.authorAyşe Nur Demiral
dc.contributor.authorSerap Akyürek
dc.contributor.orcid0000-0002-2452-869X
dc.contributor.orcid0000-0001-8435-8074
dc.contributor.orcid0000-0002-4034-1614
dc.contributor.orcid0000-0002-3950-8616
dc.contributor.orcid0000-0002-9497-7976
dc.contributor.orcid0000-0001-8521-8073
dc.contributor.orcid0000-0003-2251-3571
dc.contributor.orcid0009-0001-4800-0064
dc.contributor.orcid0000-0002-4810-4453
dc.contributor.orcid0000-0002-7936-8582
dc.contributor.orcid0000-0001-8087-3140
dc.contributor.orcid0000-0002-4087-4760
dc.contributor.orcid0000-0002-4764-9419
dc.contributor.orcid0000-0003-1537-9562
dc.contributor.orcid0000-0003-0388-676X
dc.contributor.orcid0000-0001-8840-0233
dc.date.accessioned2025-11-13T11:59:15Z
dc.date.issued2020-08-04
dc.identifier.doihttps://doi.org/10.1111/crj.13240
dc.identifier.endpage1059
dc.identifier.issn1752-6981
dc.identifier.issue11
dc.identifier.openalexW3047061825
dc.identifier.startpage1050
dc.identifier.urihttps://hdl.handle.net/11421/8600
dc.identifier.urihttps://doi.org/10.1111/crj.13240
dc.identifier.volume14
dc.language.isoen
dc.relation.ispartofThe Clinical Respiratory Journal
dc.rightsrestrictedAccess
dc.subjectSABR volatility model
dc.subjectMedicine
dc.subjectRadiation therapy
dc.subjectStage (stratigraphy)
dc.subjectNuclear medicine
dc.subjectHazard ratio
dc.subjectLung cancer
dc.subjectConfidence interval
dc.subjectAblative case
dc.subjectRadiosurgery
dc.subjectUrology
dc.subjectInternal medicine
dc.subjectRadiology
dc.subject.sdg3
dc.titlePrognostic factors in medically inoperable early stage lung cancer patients treated with stereotactic ablative radiation therapy (SABR): Turkish Radiation Oncology Society Multicentric Study
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5042455431

Dosyalar

Koleksiyonlar

Publications